It is currently Tue Jan 27, 2015 4:32 am

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Long NYT Article - Fat Factors (microbe theory)

This was cover story of NY Times magazine a couple of weeks ago, it considers research into possible bacterial or viral component involvement in obesity. Its very good reading, and I thought it might be mildly relevant to those interested in similar theories regarding MS. I was also intrigued by discussion of gut microbes which, according to article, differ markedly between people; have both genetic and environmental influences; and could result in wide ranging health ...
Read more : Long NYT Article - Fat Factors (microbe theory) | Views : 993 | Replies : 2 | Forum : General Discussion


Efficacy of mitoxantrone and intrathecal triamcinolone acetonide treatment in chronic progressive multiple sclerosis patients.Hellwig K, Schimrigk S, Lukas C, Hoffmann V, Brune N, Przuntek H, Muller T.
Department of Neurology, St. Josef Hospital, Ruhr University Bochum, Gudrunstrasse 56, 44791 Bochum, Germany.

ABSTRACT: Treatment approaches are rare for chronic progressive patients with multiple sclerosis (MS). Objective was to evaluate the clinical benefit of repeated intrathecal application of the sustained release steroid triamcinolone acetonide or the administration ...
Read more : Mitoxantrone/Triamcinolone | Views : 1160 | Replies : 4 | Forum : General Discussion


I haven't got a clue what this research is saying but it keeps the researchers employed.

Relapses in Multiple Sclerosis and Correlation With Clinical and Biological Parameters: Presented at EFNS

10th Congress of the European Federation of Neurological Societies, Glasgow. 8th September 2006

The correlation of clinical and biological parameters with relapse in patients with multiple sclerosis (MS) demonstrates the prognostic importance of specific predictive relapse-related factors, according to a study presented here at ...
Read more : Relapses | Views : 945 | Replies : 1 | Forum : General Discussion

Infections and relapses

Infection may raise MS relapse risk

Results of a study of adults with relapsing remitting multiple sclerosis point to a significant association between viral and bacterial infections and increased risk of relapse.

Investigators, in a report in the journal Neurology, note that published epidemiologic environmental observations point to infection as a possible causative factor or trigger in the onset of MS.

"Microorganisms induce strong immune responses specific for their own antigens, but microbial infections can ...
Read more : Infections and relapses | Views : 1008 | Replies : 2 | Forum : General Discussion


This is an old story so not sure why it's news again. Seems a safe and inexpensive treatment. Not sure why they can't test it on 50 male MS patients for a year and then, if positive results are seen, add it to the armoury!

Read more : Testosterone | Views : 1866 | Replies : 10 | Forum : General Discussion

2nd infusion redux

I hesitate to tell the list this until I know something more definite but 7 minutes into my 2nd Tysabri infusion on Wednesday I had an anti-phylactic (allergic) reaction. Turned bright red, couldn't breath and felt like the top of my head was going to explode. Also managed to lose my breakfast. The nurse turned off the Tysabri and gave me Benedril and 250 mg of solumedrol. Not fun but all I could think was ...
Read more : 2nd infusion redux | Views : 6054 | Replies : 23 | Forum : Tysabri (Antegren or Natalizumab)


Of interest to MS patients in Atlanta



The Multiple Sclerosis Center of Atlanta (MSCA) has announced it is now administering TYSABRI® (natalizumab), the drug recently re-released by the U.S. Food and Drug Administration (FDA). TYSABRI, manufactured by Biogen Idec and Elan Corp., treats relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses. TYSABRI is the first humanized monoclonal antibody ...
Read more : Atlanta | Views : 2689 | Replies : 1 | Forum : Tysabri (Antegren or Natalizumab)

Sorry for the newbie question -- Why Avonex?

Hi, my name is Sarah and I am here to ask a slightly more detailed version of the ultimate newbie question... "why Avonex?"

I have spent a lot of time reading the wonderfully helpful boards here and I have what I think is a slightly more specific spin on this quesion -- I am most interested to hear people's thoughts on the potential for serious side effects relating to liver and other organ function.

After ...
Read more : Sorry for the newbie question -- Why Avonex? | Views : 3038 | Replies : 2 | Forum : Avonex


BioMS Medical expands pivotal multiple sclerosis trial into Spain and Germany

BioMS Medical Corp, a leading developer in the treatment of multiple sclerosis (MS), today announced it has received approval from the Spanish Agency for Medicines and Healthcare Products (SAMHP) in Spain and from the Federal Institute for Medicines and Medical Products in Germany to start patient enrolment for its pivotal phase II/III clinical trial of MBP8298, a proprietary synthetic peptide for the treatment ...
Read more : MBP8298 | Views : 1232 | Replies : 1 | Forum : Drug Pipeline


The makers of Sativex are seeking the treatment to be licenced in the UK and Europe. It has been licenced in Canada for some time. Has anyone from Canada had any experience of this treatment?

Read more : Sativex | Views : 1072 | Replies : 3 | Forum : General Discussion


Login  •  Register


Total posts 223237 • Total topics 23206 • Total members 14685

Contact us | Terms of Service